newsfilter
← Latest News
Business Wire·

Acceleron Reports First Quarter 2021 Financial Results

- PULSAR Phase 2 trial results published in New England Journal of Medicine - - Updates from the PULSAR and SPECTRA Phase 2 trials of sotatercept in patients with pulmonary arterial hypertension (PAH) to be presented at the American Thoracic Society